|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 27, 2015 ) An industry insider described the negotiations with the Japanese government for the 2014 biennial pricing reform as tough. Yet the end result was clearly favourable to research-based companies. The system - while complex - remains timely, transparent, equitable, relatively stable and above all predictable. Launch prices are high by international standards and there are few prescribing or reimbursement barriers. More and more innovative brands are also retaining their prices during patent life. Japan is a must for any serious biopharmaceutical company to penetrate. But first you need to know the rules.
To Read the Complete Report with Toc Visit: http://www.researchmoz.us/pharmaceutical-pricing-and-distribution-in-japan-2014-update-report.html
This latest, fully-updated and greatly enlarged report from a critically-acclaimed series is the most comprehensive English-language text on optimising market access and life cycle management in the world’s second-largest pharmaceutical market.
New drug pricing, price revision processes, provider remuneration and patient contribution fully explained.
Incorporates all pricing & reimbursement rule changes coming into effect from April 2014 with forecast of fiscal 2016 reforms, including HTA.
Covers Rx brands, generics, biosimilars and OTCs.
Find out how successful companies make the pricing rules work to their advantage.
Pricing formulae, case studies, analyses, insight, hundreds of named examples. It’s all here. Almost 50% larger than the 2012 Update, but at the same price.
Written by an acknowledged expert on the Japanese market – 15 major reports published over 27 years.
Fully researched through interviews conducted in Japan in Spring 2014.
Key role of wholesalers and how they are paid clarified.
Click Here To Download The sample Copy Of This Report: http://www.researchmoz.us/enquiry.php?type=sample&repid=291326
Table of Contents:-
Executive Summary
1. Market Overview
1.1 Healthcare System
1.2 Leading Companies
1.3 R&D
1.4 Sales and Marketing
1.5 Leading Products
1.6 Foreign Exchange Rates
2. Market Access
2.1 Compassionate Use
2.2 Marketing Authorisation
2.3. Launch Principles and Timings
2.4 Reimbursement Coverage
2.5 Outline of Introductory Pricing Procedures
2.6 Data Requirements
2.7 Summary of Approach Taken
2.8 Details of Methodology
2.8.1 Similar Efficacy Comparison Method I
Click here for ENQUIRY about this report at: http://www.researchmoz.us/enquiry.php?type=enquiry&repid=291326
Whether the challenge is entering the Japanese market for the first time, moving up the all-important ranking by market share, or negotiating with a local in-licensing partner, this easy to navigate report is designed to help you quickly get a complete grasp of Japanese P&R.
About Us:
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Mr. Nachiket
Tel:+1-518-618-1030
Toll Free: 866-997-4948
Email: sales@researchmoz.us
Blog: http://china-industry-analyzer.blogspot.com/
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-618-1030
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
